Print

NuGEN Technologies, Inc. and KREATECH Biotechnology B.V. Ink Agreement to Commercialize Fragmentation and Labeling Module for Use With NuGEN's Ovation(TM) Amplification Solutions  
7/19/2007 12:15:41 PM

SAN CARLOS, Calif. & AMSTERDAM, The Netherlands--(BUSINESS WIRE)--NuGEN Technologies, Inc., a privately held company that develops and commercializes highly sensitive nucleic acid amplification and labeling systems, and Kreatech Biotechnology, maker of innovative labeling products for diagnostic and research applications, announced today an agreement that will enable NuGEN to market FL-Ovation™ cDNA Fluorescent Modules designed to complement its popular family of Ovation™ RNA amplification products. Together, the systems will provide life science researchers with a flexible and sensitive RNA sample preparation workflow for use on Agilent DNA microarrays for gene expression analysis.
//-->